2023 MSK Cardio-Oncology Symposium


2023 MSK Cardio-Oncology Symposium Banner

Add to Calendar 2023 MSK Cardio-Oncology Symposium 5/11/2023 8:00:00 AM 5/12/2023 6:00:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/course/courseoverview?EID=36575 Description: The discovery of new cancer therapeutics has significantly improved cancer survival but often at the expense of exposure to treatment that have long term and short-term cardiovascular effects. These cardiovascular complications have major impact on mortality and mortality, at times exceeding that of the primary malignancy. With cancer mortality decreasing, cardiovascular disease has emerged as a for... Zuckerman Research Center, 417 East 68th Street false MM/DD/YYYY


Date & Location
Thursday, May 11, 2023, 8:00 AM - Friday, May 12, 2023, 6:00 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY

Specialties
Specialties - Bone Marrow Transplant, Breast Medical Oncology, Cardiology, Critical Care, Emergency Medicine, Gastrointestinal Oncology, General and Family Practice, Genitourinary Oncology, Geriatric Medicine, Gynecologic Oncology, Head and Neck Oncology, Hematology, Hospice and Palliative Medicine, Hospitalist, Internal Medicine, Leukemia, Lymphoma, Medical Oncology, Nurse Practitioner, Nursing, Oncology and Hematology, Physician Assistant, Radiation Oncology, Solid Tumor Oncology

Overview

The discovery of new cancer therapeutics has significantly improved cancer survival but often at the expense of exposure to treatment that have long term and short-term cardiovascular effects. These cardiovascular complications have major impact on mortality and mortality, at times exceeding that of the primary malignancy.

With cancer mortality decreasing, cardiovascular disease has emerged as a formidable competing cause of death. Cancer survivors now demonstrate 2-5 times higher risk of mortality due to cardiovascular disease than the general population, threatening to limit the gains achieved in cancer survival. In response to the growing concerns of the CV challenges faced by patients with cancer, the field of cardio-oncology has evolved, which consists of experts in both cancer and cardiology working to improve the detection, monitoring and treatment of CV disease at each stage of the cancer care continuum. The field is rapidly growing as it advances to meet the urgent need to improve the cardiovascular health of patients with cancer.

Join us in-person in New York City for this state-of-the-art, comprehensive, case-based curriculum that addresses important clinical topics relevant to the cardiovascular health of patients with cancer. Together, an interdisciplinary group, consisting of cardiology and oncology experts from Memorial Sloan Kettering Cancer Center and around the world, will present the latest research and contemporary practice strategies in prevention, early diagnosis, and management of cardiovascular disease in patients with cancer.

This meeting will provide a forum for networking and professional collaboration. All presentations will include devoted time for interaction between audience members and presenters. Additionally, a complimentary networking reception will be held on Thursday, May 11, 2023, following the meeting, to provide an opportunity for the cardio-oncology community to interact and get to know each other. Please RSVP for the networking reception during registration. We hope to see you there!

For additional details, view the course brochure and agenda.

Additionally, registrants will receive access to an online syllabus after the Symposium, which will include video recordings of the lectures. The syllabus will be available for three months after the Symposium.

Who Should Attend

This symposium is intended for cardiologists, internists, hematologists/oncologists and other affiliated healthcare professionals who are involved in the care of cancer patients or have an interest in the field of cardio-oncology.

Objectives
  1. Describe contemporary breast cancer treatment and best practices in cardiotoxicity monitoring and management.
  2. Define the role of immunotherapy in cancer therapy and their associated cardiovascular effects.
  3. Discuss conventional and modern cancer therapy for hematologic malignancies, the oncologic indications and their associated cardiotoxicities.
  4. Explain the contemporary management of prostate cancer and the optimal cardioprotective strategy to optimize cardiovascular health.
  5. State the diagnostic and treatment strategies for cardiac amyloidosis including advances in therapy.
  6. Recognize the change in radiation therapy over time and identify best practices in monitoring and managing the cardiovascular side effects.
  7. Apply evidence-based strategies for primary and secondary prevention of cardiotoxicity during and after therapy.
  8. Recognize the appropriate use of imaging modalities for cardiotoxicity monitoring - which modality, how often and which patient?
  9. State the late cardiovascular sequelae of cancer and its treatment and the best approach to manage the cardiovascular health of cancer survivors.
  10. Illustrate the challenges of managing cardiovascular disease in cancer patients during and after cancer treatment.

Registration

Course registration includes continental breakfast, lunch, refreshment breaks, and an invitation to the networking reception on Thursday evening. Please contact [email protected] at least one week prior to the course if you have any special dietary requests or require any specific accommodations.

While MSK requests that institutional guests are vaccinated against COVID-19, we are no longer requiring proof of vaccination. Additional details, including our current Health and Safety Protocols, can be accessed on our Visiting Us page. If you are not feeling well or exhibiting any symptoms of COVID-19, please refrain from attending an in-person event at MSK and contact [email protected] as soon as possible.

Registration Fees

  • Physicians (MDs, PhDs, and DOs): $550
  • Advanced Practice Providers: $400 
  • Residents, Fellows, Nurses, and Other Healthcare Providers: $350
  • Industry Professionals: $965*
  • MSK Employees: Complimentary

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

A registration discount is available for MSK Alumni and MSK Cancer Alliance members to attend. If you are a member of one of these groups, contact [email protected] for details. Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

Cancellation Policy

If you wish to cancel your participation in this course, you must email [email protected] at least seven (7) days prior to the start of the course, and your refund will be subject to a $25 administrative fee. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 16.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 16.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.